Sign in
4/A

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-004490

Options or other derivatives

  • Director acquired 29,205 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-13 Grant or award : show line 1 in the form Stock Option (right to buy) +29,205 29,205 D
Loading xslF345X05/form4a-02212024_120255.xml…